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Background: The demographic profile of multiple sclerosis (MS) implicates gender as an 
important factor in influencing disease risk and clinical course. Sex hormones may be 
important in mediating gender differences in MS, but their influence on MS risk remains 
largely uncharacterised. We hypothesize that an altered balance of sex hormones in males 
with gender identity disorders (GID) will both inherently, and secondary to treatment in 
undergoing male-to-female conversion (which typically involves taking feminizing 
hormones, anti-androgens and/or sex reassignment surgery), increase MS risk. 
Objective: To investigate a potential association between GID and subsequent MS risk. 
Methods: We analysed linked English national Hospital Episode Statistics from 1999 to 
2011. A cohort of males with GID and a cohort of females with GID were constructed by 
identifying the first episode of day-case care or hospital admission in which a GID or sexual 
transformation procedure was coded (using the International Classification of Diseases and 
the Office of Population Censuses and Surveys Classification of Interventions and 
Procedures). A reference cohort was similarly constructed from individuals admitted for 
various other minor medical and surgical conditions. We searched for any subsequent day-
case care or inpatient admission for, or death from, MS in these cohorts. We calculated 
rates for MS, stratified and then standardized by age, calendar year of first recorded 
admission, region of residence, and socio-economic status. 
Results: There were 1157 males and 2390 females in the GID cohorts, and 4.6 million males 
and 3.4 million females in the respective reference cohorts. The adjusted rate ratio (RR) of 
MS following GID in males was 6.63 (95% confidence interval (95%CI) 1.81-17.01, p=0.0002), 
based on 4 observed cases and 0.6 expected. The adjusted RR of MS following GID in 
females was 1.44 (95%CI (0.47-3.37), p=0.58), based on 5 observed cases and 3.5 expected. 
Conclusions: We report a strong positive association (a near seven-fold elevation of rates) 
between GID and subsequent MS in males. A strength of this study is the use of a huge 
dataset to study an otherwise extremely difficult logistical undertaking. Our findings support 
a previously reported association between testicular hypofunction and MS risk, and a 
potential role for low testosterone as a MS risk factor in males. We highlight a need for 
further exploration of the influence of feminizing sex hormones on MS risk. 
 
 
